Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Sickle Cell Disease, Clinical Practice (Health Services and Quality), Diversity, Equity, and Inclusion (DEI) , Hemoglobinopathies, Diseases
Hematology Disease Topics & Pathways:
Sickle Cell Disease, Clinical Practice (Health Services and Quality), Diversity, Equity, and Inclusion (DEI) , Hemoglobinopathies, Diseases
Monday, December 12, 2022: 2:45 PM-4:15 PM
217-219
(Ernest N. Morial Convention Center)
Chair:
Alexis A. Thompson, MD, MPH, Northwestern University
Disclosures:
Thompson: Global Blood Therapeutic: Current equity holder in publicly-traded company, Membership on an entity's Board of Directors or advisory committees; Beam: Consultancy; CRISPR/Vertex: Consultancy, Research Funding; Editas: Research Funding; bluebird bio, Inc.: Consultancy, Research Funding; Bristol Myers Squibb: Consultancy, Research Funding; Novartis: Research Funding; Baxalta: Research Funding; Biomarin: Research Funding; Agios: Consultancy.
See more of: Special-Interest Sessions